Luminate
YC S21Galway, US · Founded 2019 · 55 employees · 4 known investors
Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.
BiotechDigital HealthHealthtechMedical DevicesHard TechConsumer Health Servicesin /luminate-medical@luminatemed
Founders & leadership· Y Combinator alumni (S21)
Aaron Hannonin𝕏Co-founder
Barbara Oliveirain𝕏Founder
DB
Dr. Bárbara OliveiraCo-founder
PM
Prof. Martin O'HalloranCo-founder
Investors · 4
In the news
- Luminate 2026 Midyear Report: Trends in Music, Television & Film | Luminateluminatedata.com · 2026
- Connections move us forward - Luminateluminate.org · 2026
- Lama AI raises $10M to accelerate automated loan originations - SiliconANGLEsiliconangle.com · 2026
- Luminate Raises $21M in Expanded Series A Fundingfinsmes.com · 2026
- Luminate Raises $21 Million in Funding to Expand Home Cancer Treatmentglobenewswire.com · 2026
- Apply - Luminateluminate.org · 2025
- Luminate raises $2.5m in additional funding for cancer care products – The Irish Timesirishtimes.com · 2024
- Luminate's hair-saving chemo helmet nears release, as new funding goes toward home cancer care | TechCrunchtechcrunch.com · 2024